Evaluation of Traditional Chinese Medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases

Molecules

Volumn 17, Issue 3, 2012, Pages 2955-2967

  Zuo, Guo Ying ^a   Zhang, Xin Juan ^a,b   Yang, Cui Xian ^a,c   Han, Jun ^c   Wang, Gen Chun ^a   Bian, Zhong Qi ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese medicinal plants; Inhibition zone diameters (IZD); Methicillin resistant staphylococcus aureus (MRSA); Minimal bactericidal concentrations (MIC); Traditional Chinese Medicine (TCM)

Indexed keywords

ANTIINFECTIVE AGENT; HERBACEOUS AGENT;

ARTICLE; BACTERIUM; CHEMISTRY; CHINESE MEDICINE; COMMUNICABLE DISEASE; DISK DIFFUSION; DRUG EFFECT; DRUG SCREENING; FUNGUS; HUMAN; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNICABLE DISEASES; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; FUNGI; HUMANS; MEDICINE, CHINESE TRADITIONAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PLANTS, MEDICINAL;

EID: 84858988629     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17032955     Document Type: Article

References (39)

1. Pantosti, A.; Venditti, M. What is MRSA? Eur. Respir. J. 2009, 34, 1190-1196.
2. Daniel, S. F.; Norman, R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109, 69-75.
3. Mahady, G. B. Medicinal plants for the prevention and treatment of bacterial infections. Curr. Pharm. Des. 2005, 11, 2405-2427. (Pubitemid 40872687)
4. Gibbons, S. Phytochemicals for bacterial resistance-Strengths, weaknesses and opportunities. Planta Med. 2008, 74, 594-602. (Pubitemid 351846775)
5. Sibanda, T.; Okoh, A. I. The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr. J. Biotechnol. 2007, 6, 2886-2896.
6. The Compiler Group. Shen Nong's Materia Medica; Tianjin Ancient Books Publishing House: Tianjin, China, 2009.
7. Li, S. Z. Compendium of Materia Medica; Heilongjiang Fine Arts Publishing House: Harbin, China, 2009.
8. Jiangsu New Medical College. Dictionary of Chinese Materia Medica; Shanghai Science and Technology Press: Shanghai, China, 1977.
9. State Administration of Traditional Chinese Medicine. Chinese Materia Medica; Shanghai Science and Technology Press: Shanghai, China, 1999.
10. The Compiler Group. Compilation of Chinese herbal medicine; People's Medical Publishing House: Beijing, China, 1975.
11. The Compiler Group. Selected Yunnan Traditional Chinese Herbs; Tianjin People's Press: Tianjin, China, 1970.
12. Name of disease "Chuang-Yang". In Chinese-English Pocket Dictionary of Traditional Chinese Medicine; Zhang, T. M., Jia, B., Liao, C. D., Eds.; People's Medical Publishing House: Beijing, China, 2003; pp. 47-48.
13. Tegos, G.; Stermitz, F. R.; Lomovskaya, O.; Lewis, K. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 2002, 46, 3133-3141.
14. Kumar, V. P.; Chauhan, N. S.; Padh, H.; Rajani, M. Search for antibacterial and antifungal agents from selected Indian medicinal plants. J. Ethnopharmacol. 2006, 107, 182-188. (Pubitemid 44262459)
15. Zuo, G. Y.; Wang, G. C.; Zhao, Y. B.; Xu, G. L.; Hao, X. Y.; Han, J.; Zhao, Q. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J. Ethnopharmacol. 2008, 120, 287-290.
16. Zuo, G. Y.; Wang, G. C.; Xu, G. L.; Yu, W.; Peng, H.; Kuang, W. X. Screening of anti-MRSA activity from 30 Chinese herbage medicine extracts. Chin. J. Mod. Appl. Pharm. 2006, 23, 293-295.
17. Zuo, G. Y.; Yu, W.; Xu, G. L.; Wang, G. C.; Peng, H.; Kuang, W. X. Screen of anti-MRSA activity from 18 Chinese herbage medicine extracts. China Pharm. 2005, 8, 606-608.
18. Gibbons, S. Anti-staphylococcal plant natural products. Nat. Prod. Rep. 2004, 21, 263-277. (Pubitemid 38527319)
19. Weckesser, S.; Engel, K.; Simon-Haarhaus, B.; Wittmer, A.; Pelz, K.; Schempp, C. M. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine 2007, 14, 508-516. (Pubitemid 47068952)
20. Cowan, M. M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564-582. (Pubitemid 29484747)
21. Cushnie, T. P.; Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343-356. (Pubitemid 41483464)
22. An, J.; Zuo, G. Y.; Hao, X. Y.; Wang, G. C.; Li, Z. S. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 2011, 18, 990-993.
23. Zuo, G. Y.; Meng, F. Y.; Hao, X. Y.; Zhang, Y. L.; Wang, G. C.; Xu, G. L. Antibacterial alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus. J. Pharm. Pharm. Sci. 2008, 11, 90-94.
24. Zuo, G. Y.; Li, Y.; Wang, T.; Han, J.; Wang, G. C.; Zhang, Y. L.; Pan, W. D. Synergistic antibacterial and antibiotic effects of bisbenzylisoquinoline alkaloids on clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Molecules 2011, 16, 9819-9826.
25. Meng, F. Y.; Zuo, G. Y.; Hao, X. Y.; Wang, G. C.; Xiao, H. T.; Zhang, J. Q.; Xu, G. L. Antifungal activity of the benzocphenanthridine alkaloids from Chelidonium majus Linn against resistant clinical yeast isolates. J. Ethnopharmacol. 2009, 125, 494-496.
26. Rivière, C.; Nguyen, T. H. V.; Tran, H. Q.; Chataigné, G.; Nguyen, H. N.; Dejaegher, B.; Tistaert, C.; Nguyen, T. K. T.; Vander, H. Y.; Chau, V. M.; et al. Mallotus species from Vietnamese mountainous areas: Phytochemistry and pharmacological activities. Phytochem. Rev. 2010, 9, 217-253.
27. Riviere, C.; Hong, V. N.; Pieters, L.; Dejaegher, B.; Heyden, Y. V.; Van, M. C.; Quetin-Leclercq, J. Polyphenols isolated from antiradical extracts of Mallotus metcalfianus. Phytochemistry 2009, 70, 86-94.
28. Zaidi, S. F.; Yoshida, I.; Butt, F.; Yusuf, M. A.; Usmanghani, K.; Kadowaki, M.; Sugiyama, T. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Biol. Pharm. Bull. 2009, 32, 631-636.
29. Han, Q. B.; Xu, H. X. Caged Garcinia xanthones: Development since 1937. Curr. Med. Chem. 2009, 16, 3775-3796.
30. Narasimha Rao, P. L.; Krishna Murthy, D. V.; Verma, S. C. L. Antibiotic principles of garcinia morella. Constitution of morellin. Naturwissenschaften 1954, 41, 66-67.
31. Sukpondma, Y.; Rukachaisirikul, V.; Phongpaichit, S. Antibacterial caged-tetraprenylated xanthones from the fruits of Garcinia hanburyi. Chem. Pharm. Bull. 2005, 53, 850-852. (Pubitemid 41327639)
32. Chantarasriwong, O.; Batova, A.; Chavasiri, W.; Theodorakis, E. A. Chemistry and biology of the caged Garcinia xanthones. Chemistry 2010, 16, 9944-9962.
33. Ahmad, K. F.; Sultana, N. Studies on bioassay directed antifungal activity of medicinal plants Calotropis procera, Skimmia laureola, Pettophorum pterocarpum and two pure natural compounds ulopterol and 4-methoxy-l-methyl-3- (2'-S-hydroxy-3'-ene-butyl)-2-quinolone. J. Chem. Soc. Pakistan 2003, 25, 328-330. (Pubitemid 38789901)
34. Seed Plants of Honghe Region in SE Yunnan, China; Shui, Y. M., Ed.; Yunnan Science and Technology Press: Kunming, China, 2003.
35. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard, Document M2-A9, 9th ed.; CLSI: Wayne, PA, USA, 2006.
36. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing-17th Informational Supplement, Approved Standard, M100-S17; CLSI: Wayne, PA, USA, 2007.
37. Khan, R.; Islam, B.; Akram, M.; Shakil, S.; Ahmad, A.; Ali, S. M.; Siddiqui, M.; Khan, A. U. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules 2009, 14, 586-597.
38. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, Document M7; CLSI: Wayne, PA, USA, 2006.
39. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity Antimicrobial Agents, Approved Guidelines, Document M26-A; CLSI (formerly NCCLS): Wayne, PA, USA, 1999.